Ocumension Therapeutics (FRA:5DG)
Germany · Delayed Price · Currency is EUR 0.7650
0.00 (0.00%)
Last updated: Jan 27, 2026, 8:10 AM CET
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of €649.42 million as of January 30, 2026. Its market cap has increased by 60.66% in one year.
Market Cap
649.42M
Enterprise Value
590.96M
Revenue
64.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.76
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 2.43B to 649.42M, a decrease of -73.24%. That is a compound annual growth rate of -21.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 649.42M | -1.64% |
| Dec 31, 2025 | 660.25M | 44.66% |
| Dec 31, 2024 | 456.43M | -14.58% |
| Dec 29, 2023 | 534.31M | -32.64% |
| Dec 30, 2022 | 793.26M | -39.71% |
| Dec 31, 2021 | 1.32B | -21.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 701.68M |
| FRoSTA Aktiengesellschaft | 656.73M |
| Südwestdeutsche Salzwerke AG | 640.96M |